On an MRI of the spine, multiple sclerosis typically appears as small, bright spots on the outer edges of the spinal cord. These lesions light up on certain scan types because they contain inflammation or damage to the protective coating around nerve fibers. Their size, shape, and location follow patterns that help radiologists distinguish MS from other conditions that can affect the spinal cord.
How MS Lesions Appear on Different Scan Types
Most spinal MRI protocols include several types of imaging sequences, and MS lesions look different on each one. On T2-weighted scans, lesions appear as bright white spots against the darker background of normal spinal cord tissue. These bright areas, sometimes called “hyperintensities,” indicate spots where inflammation or demyelination has changed the water content of the tissue. T2 scans are the workhorse of MS imaging because they’re good at showing the total number of lesions, both old and new.
On T1-weighted scans, the same lesions may appear as dark spots. When a lesion shows up as persistently dark on T1 imaging, it’s often called a “black hole,” which suggests more severe, permanent damage where nerve fibers have been lost and replaced by scar tissue. Not every T2-bright lesion will show up as a black hole on T1. The ones that do tend to represent older, more destructive damage rather than fresh inflammation.
A specialized sequence called STIR is particularly valuable for spinal cord imaging. In the cervical spine (the neck region), STIR catches about 90% of lesions, compared to only about 51% with standard T2 imaging alone. In the thoracic spine (mid-back), STIR performs even better relative to other sequences, detecting roughly 94% of lesions. This is partly because the thoracic spine is surrounded by more fatty tissue, which can obscure lesions on other scan types. Adding STIR to the standard protocol significantly increases the total number of lesions detected.
Size and Shape of Spinal MS Lesions
MS lesions in the spinal cord are characteristically small. A multi-center study in Japan found that the median length of an MS spinal lesion is about 13 millimeters, roughly half an inch. This held true whether the lesion was in the cervical or thoracic cord. The lesions tend to be oval or cigar-shaped when viewed from the side, spanning fewer than two vertebral segments in length.
This small size is one of the most important distinguishing features. A condition called neuromyelitis optica spectrum disorder (NMOSD), which can mimic MS, produces spinal lesions with a median length of 47 millimeters, more than three times longer. NMOSD lesions in the thoracic cord can stretch even further, with a median around 63 millimeters. So when a radiologist sees a long, continuous lesion spanning three or more vertebral segments, it raises suspicion for something other than MS.
Where Lesions Sit Within the Cord
If you imagine slicing the spinal cord like a salami and looking at the cross-section, MS lesions tend to sit along the outer edges of the cord, in the peripheral white matter. This is a key detail. NMOSD lesions, by contrast, tend to cluster in the central gray matter of the cord. The peripheral location of MS lesions makes sense biologically, since MS primarily attacks myelin, the insulating sheath around nerve fibers, which is concentrated in the white matter tracts running along the cord’s outer surface.
In terms of which part of the spine is affected, MS lesions most commonly appear in the cervical cord, followed by the thoracic cord. Lesions in the lower lumbar spine are less typical.
Active vs. Inactive Lesions
When a contrast dye (gadolinium) is injected during the MRI, actively inflamed lesions will “enhance,” meaning they absorb the dye and appear brighter on T1-weighted images. This enhancement indicates that the blood-brain barrier has broken down at that spot, allowing the dye to leak into the surrounding tissue. An enhancing lesion is a sign of recent or ongoing inflammation, typically within the past few weeks.
Once the inflammation settles, the lesion stops enhancing but usually remains visible as a bright spot on T2 scans. So a spinal MRI in someone with MS might show a mix: several older T2-bright lesions that don’t enhance, plus one or two newer ones that light up with contrast. This combination helps doctors determine whether the disease is currently active.
Why Spinal Lesions Matter for Diagnosis
Under the 2017 McDonald criteria, which are the standard guidelines for diagnosing MS, doctors need to show that lesions are spread across different areas of the central nervous system. The spinal cord counts as one of four recognized regions, alongside areas near the brain’s fluid-filled ventricles, the cortex, and the brainstem/cerebellum. Finding at least one T2 lesion in two of these four regions satisfies part of the diagnostic requirement called “dissemination in space.”
A spinal cord lesion can therefore play a pivotal role in confirming a diagnosis, especially when brain MRI findings are borderline or when symptoms point to spinal cord involvement. In some people, spinal lesions are discovered before any symptoms appear. Among individuals with incidental brain findings suggestive of MS but no clinical symptoms yet, about 35% were found to have cervical spinal cord lesions on imaging. The presence of these silent spinal lesions was linked to a higher chance of eventually developing clinical MS.
What a Normal Spinal MRI Rules Out
Not everyone with MS will have visible spinal cord lesions. Some people have disease that primarily affects the brain. But when spinal lesions are present, their appearance tells a specific story: small, peripheral, spanning less than two vertebral segments, and often clustered in the cervical cord. Lesions that are long and continuous, centrally located, or predominantly in the lower spine suggest the radiologist should consider alternative diagnoses like NMOSD, sarcoidosis, or vascular problems affecting the cord.
The distinction matters because these conditions require different treatments. A radiologist reading your spinal MRI will note the number of lesions, their size, their position within the cord, whether they enhance with contrast, and whether any appear as black holes on T1 imaging. Together, these details form a pattern that either fits the MS profile or points elsewhere.